LONDON, July 6, 2017 /PRNewswire/ -- Report presents summary of reimbursement situation for several procedures for treatment of deep vein thrombosis of lower extremities. Procedures, included into analysis include:Mechanical thrombectomySystemic thrombolysisCatheter-directed thrombolysisUltrasound-enhanced catheter-directed thrombolysisThe following clinical situations are considered:Stand-alone procedure, performed as primary procedure due to admission due to deep vein thrombosisProcedure, performed as secondary procedure for DVT, developed during hospital admission for coronary artery bypass grafting or hip replacementAnalysis is performed for CABG and hip replacementWith no complicationsWith DVT and no interventional treatmentWith DVT and interventional treatmentAnalysis is performed only for non-elective hospital admission with at least an overnight stay.Report includes essential information about reimbursement and national funding of the percutaneous procedures, including:Brief overview of reimbursement system for medical devicesProcedure coding for technologyDiagnosis codingPayment mechanism for technologyReimbursement tariffs for technologyRestrictions in indications or scenarios for use of technologyPolicy considerations by payers and policy-makers about technologyReimbursement information is provided for the following geographies:AustriaBelgiumDenmarkEngland (UK)FranceGermanyItalyNetherlandsNorwaySwedenSwitzerlandDownload the full report: https://www.reportbuyer.com/product/4941157/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.com
For more information: Sarah Smith
Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/percutaneous-procedures-for-deep-vein-thrombosis-300484274.html
SOURCE ReportBuyer
